<DOC>
	<DOCNO>NCT01151423</DOCNO>
	<brief_summary>The purpose study determine whether anti-von Willebrand factor Nanobody safe effective adjunctive treatment patient acquire thrombotic thrombocytopenic purpura ( TTP ) . Patients receive either placebo anti-von Willebrand factor Nanobody adjunctive therapy plasma exchange .</brief_summary>
	<brief_title>Study Assess Efficacy Safety Anti-von Willebrand Factor Nanobody Patients With Acquired Thrombotic Thrombocytopenic Purpura ( TTP )</brief_title>
	<detailed_description />
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombotic Thrombocytopenic</mesh_term>
	<criteria>18 year age old Men woman willing accept acceptable contraceptive regimen Patients clinical diagnosis TTP Necessitating plasma exchange ( one , single PE session prior randomisation study allow ) Patient accessible followup Obtained , sign date informed consent Platelet count great equal 100,000/ÂµL Severe active infection indicate sepsis ( requirement pressor without positive blood culture ) Clinical evidence enteric infection E.coli 0157 relate organism Antiphospholipid syndrome Diagnosis disseminate intravascular coagulation ( DIC ) Pregnancy breastfeed Haematopoietic stem cell bone marrow transplantationassociated thrombotic microangiopathy Known congenital TTP Active bleeding high risk bleed Uncontrolled arterial hypertension Known chronic treatment anticoagulant treatment stop safely Severe life threaten clinical condition TTP would impair participation trial Subjects malignancies result life expectation le 3 month Subjects know suspect bone marrow carcinosis Subjects comply study protocol requirement procedures Known hypersensitivity active substance excipients study drug Severe liver impairment , correspond grade 3 toxicity define CTCAE ( common terminology criterion adverse event ) scale Severe chronic renal impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>